- Investing Ideas
- /
- Swiss Pharmaceuticals & Biotech Undiscovered Gems With Strong Fundamentals
Swiss Pharmaceuticals & Biotech Undiscovered Gems With Strong Fundamentals
Results
2
0 new
High-performing small cap companies that haven't yet garnered significant analyst attention, and could lead to superior returns.
2 companies
Cosmo Pharmaceuticals
Market Cap: CHF 1.1b
Focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide.
COPN
CHF 68.90
7D
6.7%
1Y
-2.8%
Newron Pharmaceuticals
Market Cap: CHF 289.8m
A biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States.
NWRN
CHF 14.28
7D
6.4%
1Y
64.1%